Raymond James analyst Buck Horne downgrades Centerspace (NYSE:CSR) from Market Perform to Underperform.
Cardinal Health Q3 Earnings Beats Estimates On Pharmaceutical Segment Strength, Raises Annual Profit Forecast
Cardinal Health Inc (NYSE:CAH) reported Q3 FY23 adjusted EPS of $1.74, up 20% Y/Y, beating the consensus of $1.49. Sales…